文献速递免疫规划卫生政策与健康促进

病例对照疫苗效果研究:数据收集、分析与结果报告

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.
PubMed 文献 · Vaccine · 2017-04-23

病例对照方法常用于评价上市后疫苗效果,其结果可为真实世界保护水平与疫苗政策提供依据,但偏倚与混杂是重要局限。2012年专家组回顾相关经验,总结了数据收集、分析与结果报告的最佳实践建议,强调暴露评估、病例与对照接种数据收集方法一致、混杂变量采集与调整,以及报告时说明入组情况与无接种记录比例并重视置信区间而非点估计。

要点

  • 疫苗接种状态是主要暴露,但准确且低偏倚地评估可能具有挑战性。
  • 病例与对照的接种数据收集应采用相同方法与努力,并尽可能完整采集混杂变量。
  • 报告应描述入组情况与无接种记录比例,并强调疫苗效果置信区间而非点估计。

核心结论

  • 病例对照研究是评价疫苗效果的有用方法,但须重视数据收集、分析与报告以最好地支持循证疫苗政策。

研究设计与样本

  • 2012年专家组召开会议回顾近期病例对照疫苗效果研究经验,并总结数据收集、分析与结果报告的最佳实践建议。

主要发现

  • 疫苗接种状态是主要暴露,但准确且低偏倚地评估可能具有挑战性;研究者应了解与接种相关的因素及研究背景下有记录接种状态的可得性。
  • 许多儿童缺乏有记录的免疫史时,病例对照研究可能不是评价疫苗效果的有效方法。
  • 为避免偏倚,必须使用相同方法与努力从病例和对照中收集接种数据。
  • 可能混杂疾病与接种关联的变量应尽可能完整采集,并在相关时按分析计划在分析中调整。
  • 报告结果时应描述符合条件病例与对照的入组情况以及无疫苗记录史的比例,并应强调疫苗效果的置信区间而非点估计。

关键数值与推荐

  • 疫苗接种状态是主要暴露,但准确且低偏倚地评估可能具有挑战性。
  • 许多儿童缺乏有记录的免疫史时,病例对照研究可能不是评价疫苗效果的有效方法。
  • 必须使用相同方法与努力从病例和对照中收集接种数据以避免偏倚。
  • 可能混杂疾病与接种关联的变量应尽可能完整采集,并在相关时按分析计划调整。
  • 报告结果时应描述入组情况与无疫苗记录史的比例,并强调疫苗效果置信区间而非点估计。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 偏倚与混杂是该方法的 important limitations,实施不佳或解释错误的病例对照研究结果可能误导政策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The case-control methodology is frequently used to evaluate vaccine effectiveness post-licensure. The results of such studies provide important insight into the level of protection afforded by vaccines in a 'real world' context, and are commonly used to guide vaccine policy decisions. However, the potential for bias and confounding are important limitations to this method, and the results of a poorly conducted or incorrectly interpreted case-control study can mislead policies. In 2012, a group of experts met to review recent experience with case-control studies evaluating vaccine effectiveness; we summarize the recommendations of that group regarding best practices for data collection, analysis, and presentation of the results of case-control vaccine effectiveness studies. Vaccination status is the primary exposure of interest, but can be challenging to assess accurately and with minimal bias. Investigators should understand factors associated with vaccination as well as the availability of documented vaccination status in the study context; case-control studies may not be a valid method for evaluating vaccine effectiveness in settings where many children lack a documented immunization history. To avoid bias, it is essential to use the same methods and effort gathering vaccination data from cases and controls. Variables that may confound the association between illness and vaccination are also important to capture as completely as possible, and where relevant, adjust for in the analysis according to the analytic plan. In presenting results from case-control vaccine effectiveness studies, investigators should describe enrollment among eligible cases and controls as well as the proportion with no documented vaccine history. Emphasis should be placed on confidence intervals, rather than point estimates, of vaccine effectiveness. Case-control studies are a useful approach for evaluating vaccine effectiveness; however careful attention must be paid to the collection, analysis and presentation of the data in order to best inform evidence-based vaccine policies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Verani JR, Baqui AH, Broome CV, et al. Case-control vaccine effectiveness studies: Data collection, analysis and reporting results. Vaccine. 2017. PMID: 28442230. doi:10.1016/j.vaccine.2017.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。